Incannex Healthcare (NASDAQ:IXHL) Stock Price Down 1.7%

Incannex Healthcare Inc. (NASDAQ:IXHL)’s stock price traded down 1.7% on Thursday . The company traded as low as $2.38 and last traded at $2.38. 9,511 shares changed hands during trading, a decline of 96% from the average session volume of 271,512 shares. The stock had previously closed at $2.42.

Incannex Healthcare Trading Down 1.7 %

The firm’s fifty day simple moving average is $3.77 and its 200-day simple moving average is $3.17.

Incannex Healthcare (NASDAQ:IXHL) last released its quarterly earnings data on Wednesday, February 14th. The company reported ($0.33) earnings per share for the quarter.

Institutional Investors Weigh In On Incannex Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. UBS Group AG purchased a new position in Incannex Healthcare during the 1st quarter worth $25,000. Citadel Advisors LLC bought a new position in shares of Incannex Healthcare during the fourth quarter valued at about $64,000. Jane Street Group LLC lifted its position in shares of Incannex Healthcare by 38.8% during the fourth quarter. Jane Street Group LLC now owns 25,610 shares of the company’s stock valued at $72,000 after purchasing an additional 7,161 shares in the last quarter. AdvisorShares Investments LLC purchased a new position in Incannex Healthcare during the fourth quarter worth about $180,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in Incannex Healthcare in the 4th quarter worth about $379,000. 0.43% of the stock is owned by hedge funds and other institutional investors.

About Incannex Healthcare

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.